🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the long-term efficacy and safety of brexpiprazole as an adjunc...
Status
Completed
Location
US041
Start Date
2013-06
Trial ID
NCT01838681
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of switchin...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-07
Trial ID
NCT02418585
The purpose of this study is to evaluate the efficacy of switching adult pa...
Status
Completed
Location
Atlanta Center for Medical Research
Start Date
2018-05-25
Trial ID
NCT03434041
This study will determine whether combination treatment driven by patient c...
Status
Completed
Location
New York State Psychiatric Institute
Start Date
2008-08
Trial ID
NCT00742573
Major depressive disorder (MDD) is a serious medical illness associated wit...
Status
Completed
Location
For additional information regarding sites, contact 844-687-8522
Start Date
2018-07-13
Trial ID
NCT03538691
Treatments Being Tested
The purpose of this open-label, multicenter study is to assess the long ter...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-30
Trial ID
NCT02497287
The aim of this study is to evaluate the efficacy of hydroxyzine compared t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-12-30
Trial ID
NCT05737511
Treatments Being Tested
This is an outpatient study to evaluate the safety, and efficacy of RGH-188...
Status
Completed
Location
Forest Investigative Site 040
Start Date
2009-06-30
Trial ID
NCT00854100
To assess the long-term safety and tolerability of oral OPC-34712 (brexpipr...
Status
Completed
Location
Research Site
Start Date
2011-10
Trial ID
NCT01360866
Treatments Being Tested
The purpose of this study is to assess the efficacy of flexibly dosed JNJ-4...
Status
Completed
Location
NoesisPharma Research
Start Date
2017-12-12
Trial ID
NCT03321526